News and Trends 19 Feb 2018
Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?
Two clinical studies have demonstrated the capacity of Novartis’ monoclonal antibody to treat both plaque and scalp psoriasis and improve patient quality of life. Not only is Novartis leading the…